Full Text View
Tabular View
No Study Results Posted
Related Studies
A Study to Compare Efficacy and Safety of Mycamine® and Itraconazole for Preventing Fungal Infections
This study has been completed.
Study NCT00794703   Information provided by Astellas Pharma Inc

First Received on November 19, 2008.   Last Updated on February 8, 2010   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Fungemia
Fungal Infections
Additional conditions recognized in this trial
Mycoses
More general conditions related to this trial
Infection
Inflammation
Pathologic Processes
Sepsis
Systemic Inflammatory Response Syndrome
Interventions listed in this trial
micafungin (Mycamine)
itraconazole
Additional drug interventions recognized in this trial
Hydroxyitraconazole
Micafungin
More general drug interventions related to this trial
14-alpha Demethylase Inhibitors
Anti-Infective Agents
Antifungal Agents
Enzyme Inhibitors
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Therapeutic Uses
Sponsors listed in this trial
Astellas Pharma Inc


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services